GSK agrees to buy respiratory medicine specialist Aiolos Bio for $1.4bn

UK pharma group hopes acquisition of three-month start-up will broaden its range of asthma treatments
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news